Advertisement
Review Article| Volume 34, ISSUE 1, P137-156, March 2014

Download started.

Ok

New Molecular Genetic Tests in the Diagnosis of Heart Disease

Published:January 16, 2014DOI:https://doi.org/10.1016/j.cll.2013.11.011

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Teekakirikul P.
        • Kelly M.A.
        • Rehm H.L.
        • et al.
        Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era.
        J Mol Diagn. 2013; 15: 158-170
        • Ackerman M.J.
        • Priori S.G.
        • Willems S.
        • et al.
        HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
        Heart Rhythm. 2011; 8: 1308-1339
      1. NCBI. Genetic testing registry. Available at: http://www.ncbi.nlm.nih.gov/gtr/. Accessed September 15, 2013.

        • Maron B.J.
        • Gardin J.M.
        • Flack J.M.
        • et al.
        Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary Artery Risk Development in (Young) Adults.
        Circulation. 1995; 92: 785-789
        • Cirino A.L.
        • Ho C.Y.
        Familial Hypertrophic Cardiomyopathy Overview.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2011 (Available at:)
        • Frey N.
        • Luedde M.
        • Katus H.A.
        Mechanisms of disease: hypertrophic cardiomyopathy.
        Nat Rev Cardiol. 2012; 9: 91-100
        • Taylor D.O.
        • Edwards L.B.
        • Boucek M.M.
        • et al.
        Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report–2007.
        J Heart Lung Transplant. 2007; 26: 769-781
        • Codd M.B.
        • Sugrue D.D.
        • Gersh B.J.
        • et al.
        Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975–1984.
        Circulation. 1989; 80: 564-572
        • Herman D.S.
        • Lam L.
        • Taylor M.R.G.
        • et al.
        Truncations of titin causing dilated cardiomyopathy.
        N Engl J Med. 2012; 366: 619-628
        • Lakdawala N.K.
        • Funke B.H.
        • Baxter S.
        • et al.
        Genetic testing for dilated cardiomyopathy in clinical practice.
        J Card Fail. 2012; 18: 296-303
        • Hershberger R.
        • Morales A.
        Dilated Cardiomyopathy Overview.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2013 (Available at:)
        • Fatkin D.
        • MacRae C.
        • Sasaki T.
        • et al.
        Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.
        N Engl J Med. 1999; 341: 1715-1724
        • Hershberger R.E.
        • Parks S.B.
        • Kushner J.D.
        • et al.
        Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy.
        Clin Transl Sci. 2008; 1: 21-26
        • Toib A.
        • Grange D.K.
        • Kozel B.A.
        • et al.
        Distinct clinical and histopathological presentations of Danon cardiomyopathy in young women.
        J Am Coll Cardiol. 2010; 55: 408-410
        • Stähli B.E.
        • Gebhard C.
        • Biaggi P.
        • et al.
        Left ventricular non-compaction: prevalence in congenital heart disease.
        Int J Cardiol. 2013; 167: 2477-2481
        • Ichida F.
        • Hamamichi Y.
        • Miyawaki T.
        • et al.
        Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background.
        J Am Coll Cardiol. 1999; 34: 233-240
        • Finsterer J.
        Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction.
        Pediatr Cardiol. 2009; 30: 659-681
        • Chin T.K.
        • Perloff J.K.
        • Williams R.G.
        • et al.
        Isolated noncompaction of left ventricular myocardium. A study of eight cases.
        Circulation. 1990; 82: 507-513
        • Nava A.
        • Thiene G.
        • Canciani B.
        • et al.
        Familial occurrence of right ventricular dysplasia: a study involving nine families.
        J Am Coll Cardiol. 1988; 12: 1222-1228
        • McNally E.
        • MacLeod H.
        • Dellefave L.
        Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy, Autosomal Dominant.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2009 (Available at:)
        • Quarta G.
        • Muir A.
        • Pantazis A.
        • et al.
        Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria.
        Circulation. 2011; 123: 2701-2709
        • den Haan A.D.
        • Tan B.Y.
        • Zikusoka M.N.
        • et al.
        Comprehensive desmosome mutation analysis in North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
        Circ Cardiovasc Genet. 2009; 2: 428-435
        • Marcus F.I.
        • McKenna W.J.
        • Sherrill D.
        • et al.
        Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.
        Eur Heart J. 2010; 31: 806-814
        • Lombardi R.
        • Marian A.J.
        Molecular genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy: a disease of cardiac stem cells.
        Pediatr Cardiol. 2011; 32: 360-365
        • Saffitz J.E.
        • Asimaki A.
        • Huang H.
        Arrhythmogenic right ventricular cardiomyopathy: new insights into mechanisms of disease.
        Cardiovasc Pathol. 2010; 19: 166-170
        • Perrin M.J.
        • Gollob M.H.
        Genetics of cardiac electrical disease.
        Can J Cardiol. 2013; 29: 89-99
        • Brugada R.
        • Campuzano O.
        • Brugada P.
        • et al.
        Brugada Syndrome.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2012 (Available at:)
        • Alders M.
        • Mannens M.
        Romano-Ward Syndrome.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2012 (Available at:)
        • Tranebjaerg L.
        • Samson R.
        • Green G.
        Jervell and Lange-Nielsen Syndrome.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2012 (Available at:)
        • Napolitano C.
        • Priori S.
        • Bloise R.
        Catecholaminergic Polymorphic Ventricular Tachycardia.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2013 (Available at:)
        • Schwartz P.J.
        • Stramba-Badiale M.
        • Crotti L.
        • et al.
        Prevalence of the congenital long-QT syndrome.
        Circulation. 2009; 120: 1761-1767
        • Hazle M.A.
        • Shellhaas R.A.
        • Bradley D.J.
        • et al.
        Arrhythmogenic channelopathy syndromes presenting as refractory epilepsy.
        Pediatr Neurol. 2013; 49: 134-137
        • Schwartz P.J.
        • Spazzolini C.
        • Crotti L.
        • et al.
        The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome.
        Circulation. 2006; 113: 783-790
        • Abriel H.
        • Zaklyazminskaya E.V.
        Cardiac channelopathies: genetic and molecular mechanisms.
        Gene. 2013; 517: 1-11
        • Mahida S.
        • Ellinor P.T.
        New advances in the genetic basis of atrial fibrillation.
        J Cardiovasc Electrophysiol. 2012; 23: 1400-1406
        • Milewicz D.M.
        • Regalado E.
        Thoracic Aortic Aneurysms and Aortic Dissections.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2012 (Available at:)
        • Guo D.C.
        • Pannu H.
        • Tran-Fadulu V.
        • et al.
        Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections.
        Nat Genet. 2007; 39: 1488-1493
        • Paterick T.E.
        • Humphries J.A.
        • Ammar K.A.
        • et al.
        Aortopathies: etiologies, genetics, differential diagnosis, prognosis and management.
        Am J Med. 2013; 126: 670-678
        • Tang P.C.
        • Coady M.A.
        • Lovoulos C.
        • et al.
        Hyperplastic cellular remodeling of the media in ascending thoracic aortic aneurysms.
        Circulation. 2005; 112: 1098-1105
        • Pepin M.
        • Byers P.
        Ehlers-Danlos Syndrome Type IV.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2011 (Available at:)
        • Regalado E.S.
        • Guo D.C.
        • Villamizar C.
        • et al.
        Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms.
        Circ Res. 2011; 109: 680-686
        • van de Laar I.M.
        • Oldenburg R.A.
        • Pals G.
        • et al.
        Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.
        Nat Genet. 2011; 43: 121-126
        • Faiyaz-Ul-Haque M.
        • Zaidi S.H.E.
        • Wahab A.A.
        • et al.
        Identification of a p.Ser81Arg encoding mutation in SLC2A10 gene of arterial tortuosity syndrome patients from 10 Qatari families.
        Clin Genet. 2008; 74: 189-193
        • Pomianowski P.
        • Elefteriades J.A.
        The genetics and genomics of thoracic aortic disease.
        Ann Cardiothorac Surg. 2013; 2: 271-279
        • Loeys B.L.
        • Dietz H.C.
        • Braverman A.C.
        • et al.
        The revised Ghent nosology for the Marfan syndrome.
        J Med Genet. 2010; 47: 476-485
        • Gillis E.
        • Van Laer L.
        • Loeys B.L.
        Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-β signaling and vascular smooth muscle cell contractility.
        Circ Res. 2013; 113: 327-340
        • Dietz H.C.
        Marfan Syndrome.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2011 (Available at:)
        • Mátyás G.
        • Alonso Sira
        • Patrignani A.
        • et al.
        Large genomic fibrillin-1 (FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome.
        Hum Genet. 2007; 122: 23-32
        • Reinhardt D.P.
        • Ono R.N.
        • Notbohm H.
        • et al.
        Mutations in calcium-binding epidermal growth factor modules render fibrillin-1 susceptible to proteolysis. A potential disease-causing mechanism in Marfan syndrome.
        J Biol Chem. 2000; 275: 12339-12345
        • Loeys B.L.
        • Dietz H.C.
        Loeys-Dietz Syndrome.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2013 (Available at:)
        • Gupta P.A.
        • Putnam E.A.
        • Carmical S.G.
        • et al.
        Ten novel FBN2 mutations in congenital contractural arachnodactyly: delineation of the molecular pathogenesis and clinical phenotype.
        Hum Mutat. 2002; 19: 39-48
        • Godfrey M.
        Congenital Contractural Arachnodactyly.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2012 (Available at:)
        • Zhang H.
        • Hu W.
        • Ramirez F.
        Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils.
        J Cell Biol. 1995; 129: 1165-1176
        • van der Linde D.
        • Konings E.E.M.
        • Slager M.A.
        • et al.
        Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.
        J Am Coll Cardiol. 2011; 58: 2241-2247
        • Calcagni G.
        • Digilio M.C.
        • Sarkozy A.
        • et al.
        Familial recurrence of congenital heart disease: an overview and review of the literature.
        Eur J Pediatr. 2007; 166: 111-116
        • Zaidi S.
        • Choi M.
        • Wakimoto H.
        • et al.
        De novo mutations in histone-modifying genes in congenital heart disease.
        Nature. 2013; 498: 220-223
        • van der Bom T.
        • Zomer A.C.
        • Zwinderman A.H.
        • et al.
        The changing epidemiology of congenital heart disease.
        Nat Rev Cardiol. 2011; 8: 50-60
        • Fahed A.C.
        • Gelb B.D.
        • Seidman J.G.
        • et al.
        Genetics of congenital heart disease: the glass half empty.
        Circ Res. 2013; 112: 707-720
        • Peeters H.
        • Devriendt K.
        Human laterality disorders.
        Eur J Med Genet. 2006; 49: 349-362
        • Metcalfe K.
        • Rucka A.K.
        • Smoot L.
        • et al.
        Elastin: mutational spectrum in supravalvular aortic stenosis.
        Eur J Hum Genet. 2000; 8: 955-963
        • Urbán Z.
        • Michels V.V.
        • Thibodeau S.N.
        • et al.
        Isolated supravalvular aortic stenosis: functional haploinsufficiency of the elastin gene as a result of nonsense-mediated decay.
        Hum Genet. 2000; 106: 577-588
        • Loyd J.
        • Phillips J.I.
        Heritable Pulmonary Arterial Hypertension.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2012 (Available at:)
        • Humbert M.
        • Sitbon O.
        • Chaouat A.
        • et al.
        Pulmonary arterial hypertension in France: results from a national registry.
        Am J Respir Crit Care Med. 2006; 173: 1023-1030
        • Rabinovitch M.
        Molecular pathogenesis of pulmonary arterial hypertension.
        J Clin Invest. 2012; 122: 4306-4313
        • Schermuly R.T.
        • Ghofrani H.A.
        • Wilkins M.R.
        • et al.
        Mechanisms of disease: pulmonary arterial hypertension.
        Nat Rev Cardiol. 2011; 8: 443-455
        • Grody W.W.
        • Griffin J.H.
        • Taylor A.K.
        • et al.
        American College of Medical Genetics consensus statement on factor V Leiden mutation testing.
        Genet Med. 2001; 3: 139-148
        • American College of Obstetricians and Gynecologists Women's Health Care Physicians
        ACOG practice bulletin no. 138: inherited thrombophilias in pregnancy.
        Obstet Gynecol. 2013; 122: 706-717
        • Hickey S.E.
        • Curry C.J.
        • Toriello H.V.
        ACMG practice guideline: lack of evidence for MTHFR polymorphism testing.
        Genet Med. 2013; 15: 153-156
        • Baglin T.
        • Gray E.
        • Greaves M.
        • et al.
        Clinical guidelines for testing for heritable thrombophilia.
        Br J Haematol. 2010; 149: 209-220
        • Varga E.A.
        • Kujovich J.L.
        Management of inherited thrombophilia: guide for genetics professionals.
        Clin Genet. 2012; 81: 7-17
        • Khan S.
        • Dickerman J.D.
        Hereditary thrombophilia.
        Thromb J. 2006; 4: 15
        • Silverstein M.D.
        • Heit J.A.
        • Mohr D.N.
        • et al.
        Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.
        Arch Intern Med. 1998; 158: 585-593
        • Fowkes F.J.
        • Price J.F.
        • Fowkes F.G.
        Incidence of diagnosed deep vein thrombosis in the general population: systematic review.
        Eur J Vasc Endovasc Surg. 2003; 25: 1-5
        • Ackerman M.J.
        • Priori S.G.
        • Willems S.
        • et al.
        HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
        Europace. 2011; 13: 1077-1109
        • Green R.C.
        • Berg J.S.
        • Grody W.W.
        • et al.
        ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
        Genet Med. 2013; 15: 565-574
        • Preuss C.
        • Andelfinger G.
        Genetics of heart failure in congenital heart disease.
        Can J Cardiol. 2013; 29: 803-810
        • Kujovich J.
        Factor V Leiden Thrombophilia.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2010 (Available at:)
        • Kujovich J.
        Prothrombin-Related Thrombophilia.
        in: Pagon R. Adam M. Bird T. GeneReviews [Internet]. University of Washington, Seattle (WA)2011 (Available at:)